Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Agenix Limited

Our VisionAgenix aims to continue to be at the forefront of biotechnology, with a major focus on the development of monoclonal antibodies into innovative medical products.

Corporate Overview
Agenix Limited is a leading edge biotechnology company with operations through its wholly owned subsidiary AGEN Biomedical Limited ("AGEN")

AGEN specialises in advanced medical diagnosis of human diseases and is well positioned as a world-class thrombosis and blood clot specialist. Building on existing technology platforms, AGEN is continuously investing in research and development. AGEN is in the process of commercialising a breakthrough technology in blood clot imaging called ThromboView®.


Contact Details:
7 Durbell Street
Acacia Ridge
QLD 4110,
Australia
Tel:61 7 3370 6300
Fax:61 7 3370 6370
Email:info@agen.com.au
WWW:

www.agen.com.au/




Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 215 times since April 2007, the link to the organisation's website has been followed 41 times

Search for more companies in Acacia Ridge

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Agenix Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.